Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Messmer

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Therapeutic Drug Monitoring|October 6, 2022
Peptide Mimotope-Enabled Quantification of Natalizumab Arm Exchange During Multiple Sclerosis TreatmentLesley J Page, Jacqueline Lagunas-Acosta, Raphaela Heussen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 1999
Two human neonatal IgM antibodies encoded by different variable-region genes bind the same linear peptide: evidence for a stereotyped repertoire of epitope recognitionB T Messmer, J J Sullivan, N Chiorazzi, et al.
Scientific Reports|September 29, 2018
Identification of Peptide Mimotope Ligands for NatalizumabLaura E Ruff, Jessica A Pfeilsticker, Nicholas E Johnsen, et al.
Leukemia Research|May 17, 2011
Autoantibodies against p53 are associated with chromosome 17p deletions in chronic lymphocytic leukemiaBradley T Messmer, Talia S Nour-Omid, Emanuela Ghia, et al.
Molecular Medicine (Cambridge, Mass.)|August 23, 2005
Dendritic cells from chronic lymphocytic leukemia patients are normal regardless of Ig V gene mutation statusDavorka Messmer, Gloria Telusma, Tarun Wasil, et al.
Blood|July 12, 2003
Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the cloneEmilia Albesiano, Bradley T Messmer, Rajendra N Damle, et al.
Journal of Biotechnology|December 8, 2009
DeNAno: Selectable deoxyribonucleic acid nanoparticle librariesJason M Steiner, Marta Sartor, Ana B Sanchez, et al.
Cancer Chemotherapy and Pharmacology|January 21, 2010
A general process for the development of peptide-based immunoassays for monoclonal antibodiesAna B Sanchez, Tammy Nguyen, Rhanika Dema-Ala, et al.
Multiple Sclerosis and Related Disorders|May 17, 2024
Intact natalizumab pharmacokinetics is impacted by endogenous IgG4 concentrationLesley J Page, Iona F Pay, Edward T Castellana, et al.
The AAPS Journal|September 7, 2018
Individualized Dosing of Therapeutic Monoclonal Antibodies-a Changing Treatment Paradigm?Anne S Strik, Yow-Ming C Wang, Laura E Ruff, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Therapeutic Drug Monitoring|October 6, 2022
Peptide Mimotope-Enabled Quantification of Natalizumab Arm Exchange During Multiple Sclerosis TreatmentLesley J Page, Jacqueline Lagunas-Acosta, Raphaela Heussen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 1999
Two human neonatal IgM antibodies encoded by different variable-region genes bind the same linear peptide: evidence for a stereotyped repertoire of epitope recognitionB T Messmer, J J Sullivan, N Chiorazzi, et al.
Scientific Reports|September 29, 2018
Identification of Peptide Mimotope Ligands for NatalizumabLaura E Ruff, Jessica A Pfeilsticker, Nicholas E Johnsen, et al.
Leukemia Research|May 17, 2011
Autoantibodies against p53 are associated with chromosome 17p deletions in chronic lymphocytic leukemiaBradley T Messmer, Talia S Nour-Omid, Emanuela Ghia, et al.
Molecular Medicine (Cambridge, Mass.)|August 23, 2005
Dendritic cells from chronic lymphocytic leukemia patients are normal regardless of Ig V gene mutation statusDavorka Messmer, Gloria Telusma, Tarun Wasil, et al.
Blood|July 12, 2003
Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the cloneEmilia Albesiano, Bradley T Messmer, Rajendra N Damle, et al.
Journal of Biotechnology|December 8, 2009
DeNAno: Selectable deoxyribonucleic acid nanoparticle librariesJason M Steiner, Marta Sartor, Ana B Sanchez, et al.
Cancer Chemotherapy and Pharmacology|January 21, 2010
A general process for the development of peptide-based immunoassays for monoclonal antibodiesAna B Sanchez, Tammy Nguyen, Rhanika Dema-Ala, et al.
Multiple Sclerosis and Related Disorders|May 17, 2024
Intact natalizumab pharmacokinetics is impacted by endogenous IgG4 concentrationLesley J Page, Iona F Pay, Edward T Castellana, et al.
The AAPS Journal|September 7, 2018
Individualized Dosing of Therapeutic Monoclonal Antibodies-a Changing Treatment Paradigm?Anne S Strik, Yow-Ming C Wang, Laura E Ruff, et al.
Pageof 4